Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
Sponsor: Daewoong Pharmaceutical Co. LTD.
Summary
This observational study is a non-interventional, multi-center, prospective observational study aimed at tracking the efficacy and safety of Envlo or Envlomet SR tablets for 24 weeks in patients with type 2 diabetes and hypertension or dyslipidemia who are currently taking or are scheduled to take Envlo or Envlomet SR tablets in an actual clinical setting.
Official title: A Multi-Center, Observational Study to Evaluate the Efficacy and Safety of Enavogliflozin in Patients With Type II Diabetes Mellitus Accompanied by Hypertension or Dyslipidemia
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
12000
Start Date
2024-12-03
Completion Date
2026-06-30
Last Updated
2025-01-23
Healthy Volunteers
No
Conditions
Interventions
Envlo Tablet
Envlo Tab. 0.3mg
Envlomet SR Tablet
Envlomet SR Tablet 0.3/ Metformin1,000mg
Locations (1)
Happy Yonsei Family Medicine Clinic
Seoul, South Korea